{"id":1603,"date":"2019-09-03T11:01:00","date_gmt":"2019-09-03T03:01:00","guid":{"rendered":"https:\/\/vcro.online\/?p=1603"},"modified":"2024-07-12T11:01:52","modified_gmt":"2024-07-12T03:01:52","slug":"congratulations-the-gcp-inspection-of-phase-i-cell-therapy-study-for-chronic-stroke-was-approval-by-tfda","status":"publish","type":"post","link":"https:\/\/www.vcro.com.tw\/?p=1603","title":{"rendered":"Congratulations! The GCP inspection of phase I cell therapy study for chronic stroke was approval by TFDA"},"content":{"rendered":"\n<p>Virginia Contract Research Organization Co., Ltd.(VCRO) has successfully conducted and managed the clinical operation, data management, statistical analysis, medical writing, and GCP inspection of a phase I cell therapy IND-used study. In this clinical trial, VCRO has conquered diverse challenges the fast-paced nature of an cell therapy study, and overcame all the difficulties. On Sep-2019, the study was granted with an approval by TFDA for the GCP inspection. Just another epic VCRO milestone that we are excited to share with you!<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Virginia Contract Research Organization Co., Ltd.(VCRO) has successfully conducted and managed the clinical operation, data management, statistical analysis, medical writing, and GCP inspection of a phase I cell therapy IND-used study. In this clinical trial, VCRO has conquered diverse challenges the fast-paced nature of an cell therapy study, and overcame all the difficulties. On Sep-2019, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-1603","post","type-post","status-publish","format-standard","hentry","category-vcro-express"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\r\n<title>Congratulations! The GCP inspection of phase I cell therapy study for chronic stroke was approval by TFDA - VCRO<\/title>\r\n<meta name=\"description\" content=\"Congratulations! The GCP inspection of phase I cell therapy study for chronic stroke was approval by TFDA VCRO -\" \/>\r\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\r\n<link rel=\"canonical\" href=\"https:\/\/www.vcro.com.tw\/?p=1603\" \/>\r\n<meta property=\"og:locale\" content=\"en_US\" \/>\r\n<meta property=\"og:type\" content=\"article\" \/>\r\n<meta property=\"og:title\" content=\"Congratulations! The GCP inspection of phase I cell therapy study for chronic stroke was approval by TFDA - VCRO\" \/>\r\n<meta property=\"og:description\" content=\"Congratulations! The GCP inspection of phase I cell therapy study for chronic stroke was approval by TFDA VCRO -\" \/>\r\n<meta property=\"og:url\" content=\"https:\/\/www.vcro.com.tw\/?p=1603\" \/>\r\n<meta property=\"og:site_name\" content=\"VCRO\" \/>\r\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/people\/\/100057388670681\/\" \/>\r\n<meta property=\"article:published_time\" content=\"2019-09-03T03:01:00+00:00\" \/>\r\n<meta property=\"article:modified_time\" content=\"2024-07-12T03:01:52+00:00\" \/>\r\n<meta property=\"og:image\" content=\"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png\" \/>\r\n\t<meta property=\"og:image:width\" content=\"512\" \/>\r\n\t<meta property=\"og:image:height\" content=\"512\" \/>\r\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\r\n<meta name=\"author\" content=\"VCRO\" \/>\r\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\r\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"VCRO\" \/>\r\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1603#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1603\"},\"author\":{\"name\":\"VCRO\",\"@id\":\"https:\/\/www.vcro.com.tw\/#\/schema\/person\/2f08cc59b04b0a3bd4c58d32eb630c43\"},\"headline\":\"Congratulations! The GCP inspection of phase I cell therapy study for chronic stroke was approval by TFDA\",\"datePublished\":\"2019-09-03T03:01:00+00:00\",\"dateModified\":\"2024-07-12T03:01:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1603\"},\"wordCount\":99,\"publisher\":{\"@id\":\"https:\/\/www.vcro.com.tw\/#organization\"},\"articleSection\":[\"VCRO express\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1603\",\"url\":\"https:\/\/www.vcro.com.tw\/?p=1603\",\"name\":\"Congratulations! The GCP inspection of phase I cell therapy study for chronic stroke was approval by TFDA - VCRO\",\"isPartOf\":{\"@id\":\"https:\/\/www.vcro.com.tw\/#website\"},\"datePublished\":\"2019-09-03T03:01:00+00:00\",\"dateModified\":\"2024-07-12T03:01:52+00:00\",\"description\":\"Congratulations! The GCP inspection of phase I cell therapy study for chronic stroke was approval by TFDA VCRO -\",\"breadcrumb\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1603#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.vcro.com.tw\/?p=1603\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1603#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.vcro.com.tw\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Congratulations! The GCP inspection of phase I cell therapy study for chronic stroke was approval by TFDA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.vcro.com.tw\/#website\",\"url\":\"https:\/\/www.vcro.com.tw\/\",\"name\":\"VCRO - Asia Pacific CRO Based in Taiwan\",\"description\":\"Virginia Contract Research Organization Co., Ltd.- Asia Pacific CRO Based in Taiwan\",\"publisher\":{\"@id\":\"https:\/\/www.vcro.com.tw\/#organization\"},\"alternateName\":\"VCRO\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.vcro.com.tw\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.vcro.com.tw\/#organization\",\"name\":\"Virginia Contract Research Organization Co., Ltd.\",\"alternateName\":\"VCRO\",\"url\":\"https:\/\/www.vcro.com.tw\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.vcro.com.tw\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/vcro.com.cn\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png\",\"contentUrl\":\"https:\/\/vcro.com.cn\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png\",\"width\":512,\"height\":512,\"caption\":\"Virginia Contract Research Organization Co., Ltd.\"},\"image\":{\"@id\":\"https:\/\/www.vcro.com.tw\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/people\/\/100057388670681\/\",\"https:\/\/line.me\/R\/ti\/p\/277jsobo\",\"http:\/\/weixin.qq.com\/r\/eRD64tPE0I6vrZeB90Vr\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.vcro.com.tw\/#\/schema\/person\/2f08cc59b04b0a3bd4c58d32eb630c43\",\"name\":\"VCRO\",\"sameAs\":[\"https:\/\/www.vcro.com.tw\"],\"url\":\"https:\/\/www.vcro.com.tw\/?author=1\"}]}<\/script>\r\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Congratulations! The GCP inspection of phase I cell therapy study for chronic stroke was approval by TFDA - VCRO","description":"Congratulations! The GCP inspection of phase I cell therapy study for chronic stroke was approval by TFDA VCRO -","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.vcro.com.tw\/?p=1603","og_locale":"en_US","og_type":"article","og_title":"Congratulations! The GCP inspection of phase I cell therapy study for chronic stroke was approval by TFDA - VCRO","og_description":"Congratulations! The GCP inspection of phase I cell therapy study for chronic stroke was approval by TFDA VCRO -","og_url":"https:\/\/www.vcro.com.tw\/?p=1603","og_site_name":"VCRO","article_publisher":"https:\/\/www.facebook.com\/people\/\/100057388670681\/","article_published_time":"2019-09-03T03:01:00+00:00","article_modified_time":"2024-07-12T03:01:52+00:00","og_image":[{"width":512,"height":512,"url":"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png","type":"image\/png"}],"author":"VCRO","twitter_card":"summary_large_image","twitter_misc":{"Written by":"VCRO"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.vcro.com.tw\/?p=1603#article","isPartOf":{"@id":"https:\/\/www.vcro.com.tw\/?p=1603"},"author":{"name":"VCRO","@id":"https:\/\/www.vcro.com.tw\/#\/schema\/person\/2f08cc59b04b0a3bd4c58d32eb630c43"},"headline":"Congratulations! The GCP inspection of phase I cell therapy study for chronic stroke was approval by TFDA","datePublished":"2019-09-03T03:01:00+00:00","dateModified":"2024-07-12T03:01:52+00:00","mainEntityOfPage":{"@id":"https:\/\/www.vcro.com.tw\/?p=1603"},"wordCount":99,"publisher":{"@id":"https:\/\/www.vcro.com.tw\/#organization"},"articleSection":["VCRO express"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.vcro.com.tw\/?p=1603","url":"https:\/\/www.vcro.com.tw\/?p=1603","name":"Congratulations! The GCP inspection of phase I cell therapy study for chronic stroke was approval by TFDA - VCRO","isPartOf":{"@id":"https:\/\/www.vcro.com.tw\/#website"},"datePublished":"2019-09-03T03:01:00+00:00","dateModified":"2024-07-12T03:01:52+00:00","description":"Congratulations! The GCP inspection of phase I cell therapy study for chronic stroke was approval by TFDA VCRO -","breadcrumb":{"@id":"https:\/\/www.vcro.com.tw\/?p=1603#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.vcro.com.tw\/?p=1603"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.vcro.com.tw\/?p=1603#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.vcro.com.tw\/"},{"@type":"ListItem","position":2,"name":"Congratulations! The GCP inspection of phase I cell therapy study for chronic stroke was approval by TFDA"}]},{"@type":"WebSite","@id":"https:\/\/www.vcro.com.tw\/#website","url":"https:\/\/www.vcro.com.tw\/","name":"VCRO - Asia Pacific CRO Based in Taiwan","description":"Virginia Contract Research Organization Co., Ltd.- Asia Pacific CRO Based in Taiwan","publisher":{"@id":"https:\/\/www.vcro.com.tw\/#organization"},"alternateName":"VCRO","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.vcro.com.tw\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.vcro.com.tw\/#organization","name":"Virginia Contract Research Organization Co., Ltd.","alternateName":"VCRO","url":"https:\/\/www.vcro.com.tw\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.vcro.com.tw\/#\/schema\/logo\/image\/","url":"https:\/\/vcro.com.cn\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png","contentUrl":"https:\/\/vcro.com.cn\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png","width":512,"height":512,"caption":"Virginia Contract Research Organization Co., Ltd."},"image":{"@id":"https:\/\/www.vcro.com.tw\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/people\/\/100057388670681\/","https:\/\/line.me\/R\/ti\/p\/277jsobo","http:\/\/weixin.qq.com\/r\/eRD64tPE0I6vrZeB90Vr"]},{"@type":"Person","@id":"https:\/\/www.vcro.com.tw\/#\/schema\/person\/2f08cc59b04b0a3bd4c58d32eb630c43","name":"VCRO","sameAs":["https:\/\/www.vcro.com.tw"],"url":"https:\/\/www.vcro.com.tw\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/1603","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1603"}],"version-history":[{"count":1,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/1603\/revisions"}],"predecessor-version":[{"id":1604,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/1603\/revisions\/1604"}],"wp:attachment":[{"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1603"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1603"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1603"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}